Status:
RECRUITING
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Boston Children's Hospital - Children's Rare Disease Cohorts Initiative
Conditions:
Hereditary Spastic Paraplegia
Neurodegenerative Diseases
Eligibility:
All Genders
1-30 years
Brief Summary
The purpose of the HSP Sequencing Initiative is to better understand the role of genetics in hereditary spastic paraplegia (HSP) and related disorders. The HSPs are a group of more than 80 inherited n...
Detailed Description
The hereditary spastic paraplegias (HSP) are a group of more than 80 inherited neurogenetic diseases that share the common feature of progressive spasticity. Collectively, the HSPs present the most co...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Clinical diagnosis of progressive spasticity
Exclusion
Key Trial Info
Start Date :
April 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 29 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05354622
Start Date
April 25 2022
End Date
April 29 2027
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115